This company listing is no longer active
Bionomics Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 6/6
Bionomics has a total shareholder equity of A$47.7M and total debt of A$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are A$56.3M and A$8.6M respectively.
Anahtar bilgiler
0%
Borç/özkaynak oranı
AU$0
Borç
Faiz karşılama oranı | n/a |
Nakit | AU$30.70m |
Eşitlik | AU$47.72m |
Toplam yükümlülükler | AU$8.59m |
Toplam varlıklar | AU$56.31m |
Son finansal sağlık güncellemeleri
Is Bionomics (ASX:BNO) In A Good Position To Deliver On Growth Plans?
Jun 14Is Bionomics (ASX:BNO) In A Good Position To Invest In Growth?
Feb 23Is Bionomics (ASX:BNO) In A Good Position To Deliver On Growth Plans?
Sep 14Companies Like Bionomics (ASX:BNO) Are In A Position To Invest In Growth
Nov 15Recent updates
Is Bionomics (ASX:BNO) In A Good Position To Deliver On Growth Plans?
Jun 14Is Bionomics (ASX:BNO) In A Good Position To Invest In Growth?
Feb 23Is Bionomics (ASX:BNO) In A Good Position To Deliver On Growth Plans?
Sep 14Companies Like Bionomics (ASX:BNO) Are In A Position To Invest In Growth
Nov 15Did You Miss Bionomics' (ASX:BNO) 86% Share Price Gain?
Dec 30Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: BNO's short term assets (A$33.1M) exceed its short term liabilities (A$3.7M).
Uzun Vadeli Yükümlülükler: BNO's short term assets (A$33.1M) exceed its long term liabilities (A$4.9M).
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: BNO is debt free.
Borcun Azaltılması: BNO has no debt compared to 5 years ago when its debt to equity ratio was 63.9%.
Bilanço
Nakit Pist Analizi
Geçmişte ortalama olarak zarar eden şirketler için, en az 1 yıllık nakit akışına sahip olup olmadıklarını değerlendiriyoruz.
İstikrarlı Nakit Pisti: BNO has sufficient cash runway for more than a year based on its current free cash flow.
Tahmini Nakit Akışı: BNO has sufficient cash runway for 1.7 years if free cash flow continues to reduce at historical rates of 9% each year.